ليتروزول تيڤع

main_info

  • trade_name:
  • ليتروزول تيڤع
  • pharmaceutical_form:
  • TABLETS
  • administration_route:
  • PER OS
  • medicine_domain:
  • Human
  • medicine_type:
  • Allopathic
  • manufactured_by:
  • TEVA PHARMACEUTICAL INDUSTRIES LTD

documents

localization

  • country:
  • ليتروزول تيڤع
    إسرائيل
  • language:
  • العربية

therapeutic_information

  • therapeutic_group:
  • LETROZOLE
  • therapeutic_indication:
  • Letrozole teva tablets is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whom hormone receptor status cannot be determined, locally advanced or metastatic breast cancer: Letrozole teva is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. Extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

status

  • source:
  • Ministry of Health - State of Israel
  • authorization_number:
  • 142283187800
  • authorization_date:
  • 01-01-2010
  • last_update:
  • 09-08-2016